ClinicalTrials.govpublic full text
Re-administration of Intramuscular AAV9 in Patients With Late-Onset Pompe Disease
pompe disease, gene therapy, repeated dosing, immune modulation, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 828450
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.